The Clinical Islet Transplantation Consortium is a network of clinical centers and a data coordinating center established in 2004 to conduct studies of islet transplantation in patients with type 1 diabetes.
Main Areas of Focus
- To improve the isolation and viability of islets
- To reduce complications of the islet transplant procedure (e.g., bleeding and clotting in the blood vessels of the liver)
- To reduce the side effects of immunosuppression
- To achieve good blood sugar control without hypoglycemia
- To follow the fate of islets after transplantation and determining why donor islets sometimes fail
- To evaluate new ways to safely prevent immune rejection of donor tissues